Senti Biosciences Holdings
SNTI
14 hedge funds and large institutions have $2.41M invested in Senti Biosciences Holdings in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
21% more ownership
Funds ownership: 2.27% → 23.27% (+21%)
30% less funds holding
Funds holding: 20 → 14 (-6)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
74% less capital invested
Capital invested by funds: $9.17M → $2.41M (-$6.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$70.7K |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$47.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$27.7K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Intel Corp
Santa Clara,
California
|
-$30.4K |
| 2 |
Two Sigma Investments
New York
|
-$19.3K |
| 3 |
State Street
Boston,
Massachusetts
|
-$10.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$10.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.67K |
SNTI Hedge Fund Activity: Q3 2024 in Review
14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q3 2024, worth a combined $2.41M — down 74% from $9.17M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of SNTI and 4 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $70.7K. The largest seller was Intel Corp, cutting an estimated $30.4K.
- 14 institutional investors held Senti Biosciences Holdings (SNTI) as of Q3 2024, down from 20 in Q2 2024.
- Funds reported $2.41M of Senti Biosciences Holdings stock for Q3 2024, down 74% quarter-over-quarter.
- 4 funds opened new Senti Biosciences Holdings positions in Q3 2024 and 10 closed out, a net change of -6 holders.
- The largest Senti Biosciences Holdings buyer in Q3 2024 was Vanguard Group, an estimated $70.7K added.
- The largest Senti Biosciences Holdings seller in Q3 2024 was Intel Corp, an estimated $30.4K sold.
Based on aggregated 13F filings for Q3 2024.